Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 7/20 | 0.67 |
| ▸ | LMNA | P02545 | 4/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.67 |
| ▸ | TP53 | P04637 | 2/20 | 0.66 |
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | THRB | P10828 | 1/20 | 0.63 |
| ▸ | GAA | P10253 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16922182 | 1.00 | ALDH1A1 (0.71) | ALDH1A1SMN1; SMN2MAPTLMNAHTT | |
| SCHEMBL30661080 | 1.00 | ALDH1A1 (0.71) | ALDH1A1SMN1; SMN2MAPTLMNAHTT | |
| SCHEMBL29131110 | 0.88 | ALDH1A1 (0.63) | ALDH1A1SMN1; SMN2MAPTLMNAHTT | |
| SCHEMBL30668840 | 0.88 | ALDH1A1 (0.63) | ALDH1A1SMN1; SMN2MAPTLMNAHTT | |
| SCHEMBL31048907 | 0.87 | SMN1; SMN2 (0.69) | ALDH1A1SMN1; SMN2MAPTLMNAHTT | |
| SCHEMBL11729355 | 0.87 | SMN1; SMN2 (0.69) | ALDH1A1SMN1; SMN2MAPTLMNAHTT | |
| SCHEMBL11538033 | 0.87 | SMN1; SMN2 (0.69) | ALDH1A1SMN1; SMN2MAPTLMNAHTT | |
| SCHEMBL29769836 | 0.87 | SMN1; SMN2 (0.69) | ALDH1A1SMN1; SMN2MAPTLMNAHTT | |
| SCHEMBL11659841 | 0.86 | SMN1; SMN2 (0.71) | ALDH1A1SMN1; SMN2MAPTLMNAHTT | |
| SCHEMBL13263480 | 0.86 | SMN1; SMN2 (0.71) | ALDH1A1SMN1; SMN2MAPTLMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3932325-A | Process for preparing 6-chloro-2-chloromethyl-4-phenylquinazoline-3-oxide and intermediates therefor | PFIZER INC. (US) | 1976-01-13 | — | — | US | claimed |
| US-20250213700-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR CELL-SPECIFIC PHARMACOLOGY | FOX CHASE CHEMICAL DIVERSITY CENTER, INC. | 2025-07-03 | — | — | US | disclosed |
| US-20240257921-A1 | COMPUTATIONAL GENERATION OF CHEMICAL SYNTHESIS ROUTES AND METHODS | STANFORD RES INST INT (US) | 2024-08-01 | — | — | US | disclosed |
| US-11961595-B2 | Computational generation of chemical synthesis routes and methods | SRI INTERNATIONAL (US) | 2024-04-16 | — | — | US | disclosed |
| WO-2023225369-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR CELL-SPECIFIC PHARMACOLOGY | DUKE UNIVERSITY (US) | 2023-11-23 | — | — | WO | disclosed |
| WO-2023225369-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR CELL-SPECIFIC PHARMACOLOGY | DUKE UNIVERSITY (US) | 2023-11-23 | — | — | WO | disclosed |
| CN-114031566-A | Preparation method of stable isotope labeled diazepam internal standard reagent | 谱同生物医药科技(常州)有限公司 | 2022-02-11 | — | — | CN | disclosed |
| CN-113549078-A | Preparation method of stable isotope labeled alprazolam and estazolam internal standard reagent | 谱同生物医药科技(常州)有限公司 | 2021-10-26 | — | — | CN | disclosed |
| CN-113549022-A | Preparation method of stable isotope labeled oxazepam internal standard reagent | 谱同生物医药科技(常州)有限公司 | 2021-10-26 | — | — | CN | disclosed |
| US-20210065851-A1 | COMPUTATIONAL GENERATION OF CHEMICAL SYNTHESIS ROUTES AND METHODS | SRI INTERNATIONAL | 2021-03-04 | — | — | US | disclosed |
| US-5091415-A | Antiulcer, antisecretory agents | PIERRE FABRE MEDICAMENT (FR) | 1992-02-25 | — | — | US | disclosed |
| US-5025015-A | Antisecretory and antiulcer agents | PIERRE FABRE MEDICAMENT (FR) | 1991-06-18 | — | — | US | disclosed |
| US-3998883-A | PROCESS FOR PREPARING 6-CHLORO-2-CHLOROMETHYL-4-PHENYLQUINAZOLINE-3-OXIDE AND INTERMEDIATES THEREFOR | PFIZER INC. (US) | 1976-12-21 | — | — | US | disclosed |
| US-3998883-A | PROCESS FOR PREPARING 6-CHLORO-2-CHLOROMETHYL-4-PHENYLQUINAZOLINE-3-OXIDE AND INTERMEDIATES THEREFOR | PFIZER INC. (US) | 1976-12-21 | — | — | US | disclosed |
| US-3996209-A | Process for preparing benzodiazepines | HOFFMANN-LA ROCHE INC. (US) | 1976-12-07 | — | — | US | disclosed |
| US-3950383-A | SEDATIVES, MUSCLE RELAXANTS, ANTIAGGRESSION | CASSELLA FARBWERKE MAINKUR AKT (DT) | 1976-04-13 | — | — | US | disclosed |
| US-3932325-A | Process for preparing 6-chloro-2-chloromethyl-4-phenylquinazoline-3-oxide and intermediates therefor | PFIZER INC. (US) | 1976-01-13 | — | — | US | disclosed |
| US-3932325-A | Process for preparing 6-chloro-2-chloromethyl-4-phenylquinazoline-3-oxide and intermediates therefor | PFIZER INC. (US) | 1976-01-13 | — | — | US | disclosed |
| US-3931314-A | CNS SEDATIVES, MUSCLE RELAXANTS, ANTIAGGRESSION | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | disclosed |
| US-3931301-A | SEDATIVE, ANTIAGGRESSION, MUSCLE RELAXANT | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250213700-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR CELL-SPECIFIC PHARMACOLOGY | DDT, ABCG2, CES2 | ALDH1A1 179/4885SMN1; SMN2 4515/4885MAPT 2568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.